Rallybio Corporaton (RLYB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.6700 -0.0300 (-4.29%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.6700 unch (unch) 16:00 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | RLYB | INTS | GDTC | ||
| Company | Rallybio Corporaton | Intensity Therapeutics Inc | Cytomed Therapeutics Limited | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.6919 | 1.9800 | 2.58 | ||
| High | 0.7104 | 2.1200 | 2.73 | ||
| Low | 0.6600 | 1.9400 | 2.49 | ||
| Last | 0.6700 | 2.0000 | 2.61 | ||
| Change | -0.0300 | +0.0700 | -0.05 | ||
| % Change | -4.29% | +3.63% | -1.88% | ||
| Volume | 35,400 | 43,400 | 18,200 | ||
| 20-Day Average Volume | 42,250 | 38,115 | 11,785 | ||
| Previous Close | 0.7000 | 1.9300 | 2.66 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.6992 | 2.2200 | 2.68 | ||
| 20-Day Raw Stochastic | 29.76% | 31.52% | 48.72% | ||
| 20-Day Relative Strength | 41.60% | 42.28% | 48.31% | ||
| Weighted Alpha | -64.40 | -65.56 | +8.07 | ||
| Today's Opinion | 100% Sell | 100% Sell | 56% Buy | ||
| Previous Opinion | 100% Sell | 100% Sell | 72% Buy | ||
| Last Month's Opinion | 100% Sell | 80% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.01% since 03/14/25 | -13.79% since 03/14/25 | +5.24% since 03/14/25 | ||
| Low | 0.6350 on 03/17/25 | 1.7700 on 03/19/25 | 2.48 on 03/17/25 | ||
| High | 0.7830 on 03/18/25 | 2.5000 on 03/19/25 | 2.80 on 03/17/25 | ||
| 1-Month | |||||
| %Chg | -11.14% since 02/21/25 | -10.31% since 02/21/25 | -6.79% since 02/21/25 | ||
| Low | 0.6200 on 03/13/25 | 1.7700 on 03/19/25 | 2.42 on 03/11/25 | ||
| High | 0.7880 on 02/24/25 | 2.5000 on 03/19/25 | 2.81 on 03/04/25 | ||
| 3-Month | |||||
| %Chg | -29.47% since 12/20/24 | +6.38% since 12/20/24 | +1.95% since 12/20/24 | ||
| Low | 0.6200 on 03/13/25 | 1.5000 on 01/02/25 | 2.12 on 01/15/25 | ||
| High | 1.0799 on 01/06/25 | 3.1700 on 01/16/25 | 4.05 on 01/06/25 | ||
| 6-Month | |||||
| %Chg | -39.09% since 09/20/24 | -48.45% since 09/20/24 | +68.39% since 09/19/24 | ||
| Low | 0.6200 on 03/13/25 | 1.5000 on 01/02/25 | 1.20 on 09/25/24 | ||
| High | 1.2401 on 12/11/24 | 4.0800 on 09/23/24 | 4.05 on 01/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 29,128 | 29,299 | 29,100 | ||
| Shares Outstanding, K | 41,612 | 15,181 | 10,940 | ||
| Annual Sales | 640,000 | 0 | 0 | ||
| Annual Net Income | -57,780,000 | -16,270,000 | -3,130,000 | ||
| Last Quarter Sales | 40,000 | 0 | N/A | ||
| Last Quarter Net Income | -11,040,000 | -3,180,000 | N/A | ||
| 60-Month Beta | -1.45 | 3.92 | -0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 03/13/25 | -0.22 on 03/13/25 | N/A | ||
| Latest Earnings Date | 05/08/25 | 05/08/25 | 04/28/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||